The short version of circadian clock fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-02-13. Anything still debated is marked as such rather than presented as settled.
Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.
Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.
In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.
Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.
Laboratory samples of SR9009 are typically supplied as a white to off-white powder. The compound dissolves readily in organic solvents such as dimethyl sulfoxide and ethanol, while its solubility in water is low. Because of this solubility profile, researchers often prepare concentrated stock solutions in an organic solvent before diluting them into aqueous assay buffers. Light exposure, moisture, and repeated freeze-thaw cycles can degrade many small molecules, so handling procedures usually aim to minimize these factors. Purity is commonly checked before use.
| Property | Value | Notes |
|---|---|---|
| Appearance | Off-white to pale yellow solid | Visual description varies with purity and source |
| Solubility | Soluble in DMSO and ethanol; poorly soluble in water | Organic stock solutions are common in research |
| Typical storage | -20 °C, desiccated, protected from light | Avoid repeated freeze-thaw cycles |
| Typical analytical method | LC-MS or HPLC-UV | Reference standards are needed for quantification |
| Molar mass | Approximately 437.9 g/mol | Calculated from the reported free-base formula |
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.
SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.
Research interest in SR9009 grew from studies showing improved running endurance in mice after short treatment periods. Those experiments linked the compound to increased mitochondrial content and fatty acid oxidation in muscle, but the findings come from animal models and specific dosing schedules. Independent replication has been limited, and the pathways connecting REV-ERB activation to exercise performance are still being mapped. Whether similar responses occur in humans is an open question.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
In May 2016, PD-L1 inhibitor atezolizumab was approved for treating bladder cancer. Anti-PD-L1 antibodies currently in development include avelumab and durvalumab, in addition to an inhibitory affimer.
Making models out of clay before beginning to build, the city planners remained consistent with Inca architecture and laid out a city that separated the agriculture and urban areas. Before construction began the engineers had to assess the spring and whether it could provide for all of the city’s anticipated citizens. After evaluating the water supply, the civil engineers designed a 2,457-foot (749 m)-long canal to what would become the city’s center. The canal descends the mountain slope, enters the city walls, passes through the agricultural sector, then crosses the inner wall into the urban sector, where it feeds a series of fountains. The fountains are publicly accessible and partially enclosed by walls that are typically about 1.2 m high, except for the lowest fountain, which is a private fountain for the Temple of the Condor and has higher walls. At the head of each fountain, a cut stone conduit carries the water to a rectangular spout, which is shaped to create a jet of water suitable for filling aryballos–a typical Inca clay water jug. The water collects in a stone basin in the floor of the fountain, then enters a circular drain that delivers it to the approach channel for the next fountain. The Incas built the canals on steady grades, using cut stones as the water channels. Most citizens worked on the construction and maintenance of the canal and irrigation systems, bronze and stone tools to complete the water-tight stone canals.
Karin Markides, born 1951, is a Swedish professor in analytical chemistry and president and CEO of Okinawa Institute of Science and Technology from 1 June 2023. She was the president of American University of Armenia from 1 July 2019 to 2 December 2022. She was also the president and CEO of Chalmers University of Technology from 2006 to 2015. From 2004 to 2006 she was vice director general for Vinnova. She is also board member of the Royal Swedish Academy of Engineering Sciences since 1992 and a board member of the Royal Swedish Academy of Sciences since 1999. Markides completed her doctorate degree at Stockholm University 1984 with the thesis Organosiloxanes containing cyano groups for capillary chromatography. Following this she started her research career at Brigham Young University in Utah, USA, first as a postdoc, and later as research assistant and associate director. In May 1990 she returned to Sweden as a professor at Uppsala University. Fourteen years later, in May 2004, she was employed as vice director general of Vinnova, the Swedish innovation agency. Markides has been chairman of the Scientific Council for Sustainable Development under the Swedish government (vetenskapliga rådet för hållbar utveckling) since 2015. The council's mission is to give evidence-based, concrete suggestions for development of financial, ecological, cultural and social sustainability for the government's longterm sustainability vision.
This is done in cases where distention (swelling) has a greater chance of occurring. In many cases, an embalmer may select to perform what is known as a pre-injection. A pre-injection is a solution of chemicals that do not contain any preservative chemicals, but rather chemicals that encourage vasodilation, help disperse blood clots, and act as chelating agents. The focus of this "pre-injection" is to allow for a more complete drainage and better distribution of the arterial embalming solution. Cavity treatment/embalming refers to the removal of internal fluids inside body cavities via the use of an aspirator and trocar. The embalmer pushes the trocar through the abdominal wall near the navel (two inches superior and two inches to the right) and into the abdominal and chest cavities. This first punctures the hollow organs and aspirates their contents. The embalmer then fills the cavities with concentrated chemicals (known as cavity chemicals) that may contain formaldehyde, which are delivered to the chest cavity via the trocar inserted through the diaphragm. The incision is either sutured closed (commonly using the purse-string or 'N' suture methods) or a "trocar button" is secured into place. Hypodermic embalming is a supplemental method which refers to the injection of embalming chemicals into tissue with a hypodermic needle and syringe, which is generally used as needed on a case-by-case basis to treat areas where arterial fluid has not been successfully distributed during the main arterial injection.
== Ecology == In its native habitat Vanilla planifolia depends on one or more pollinators. Several species of bee have been proposed including Euglossa species, Eulaema cingulata, Eulaema polychroma, Eulaema meriana, and Melipona beecheii for pollination. However, no definitive observation of pollination is recorded and the size of M. beecheii in particular make it unlikely to be a pollinator of this species of orchid, though unpublished observations suggest that Euglossa (reported as E. viridissima, but this species has historically been confused with other Euglossa species) might be capable of completing pollination. Attempts to document the visitation of V. planifolia in the Yucatán peninsula of Mexico failed to record any visitation by any stingless bees or orchid bees (including Melipona, Eulaema, and Euglossa), leaving the identity of its natural pollinators as yet unresolved. Though the seeds of Vanilla planifolia are very small, they are relatively large for an orchid and are not dispersed by the wind. Instead they spread through the rainforest habitat by many different animals. Male orchid bees in the tribe Euglossini in the genera Euglossa and Eulaema exhibit fragrance-collecting behavior with the fruits. Specific species observed removing seeds as part of this behavior include Euglossa bursigera, Euglossa ignita, Euglossa tridentata, and Eulaema cingulata. Conversely female stingless bees remove the pulp of the fruit in a behavior consistent with nest-building activities. The two species observed distributing V.
Sources: en.wikipedia.org
Soybeans with black hulls are used in Chinese fermented black beans, douchi, not to be confused with black turtle beans. Soybeans are also used in industrial products, including oils, soap, cosmetics, resins, plastics, inks, crayons, solvents, and clothing. Soybean oil is the primary source of biodiesel in the United States, accounting for 80% of domestic biodiesel production. Soybeans have also been used since 2001 as fermenting stock in the manufacture of a brand of vodka. In 1936, Ford Motor Company developed a method where soybeans and fibers were rolled together producing a soup which was then pressed into various parts for their cars, from the distributor cap to knobs on the dashboard. Ford also informed in public relation releases that in 1935 over five million acres (20,000 km2) was dedicated to growing soybeans in the United States.
=== 2009–2013: Time Machine Tour and Clockwork Angels === On February 16, 2009, Lifeson remarked that the band might begin working on a new album in the fall of 2009, with Nick Raskulinecz again producing. In November 2009, Lee, Lifeson and Peart were awarded the International Achievement Award at the annual SOCAN Awards in Toronto. On March 19, 2010, the CBC posted a video interview with Lee and Lifeson in which they discussed Rush's induction into the Canadian Songwriters Hall of Fame on March 28, 2010, at the Toronto Centre for the Arts' George Weston Recital Hall. The band was recognized for the songs "Limelight", "Closer to the Heart", "The Spirit of Radio", "Tom Sawyer" and "Subdivisions". In addition to discussing their induction, Lee and Lifeson touched on future material, with Lee saying, "Just about a month and a half ago we had no songs. And now we've been writing, and now we've got about 6 songs that we just love..." On March 26, 2010, in an interview with The Globe and Mail, Lifeson remarked that there was even the potential for two supporting tours. Soon afterwards, Peart confirmed that Raskulinecz had returned as co-producer. In April 2010, Rush recorded "Caravan" and "BU2B", two new songs to be featured on the band's then-upcoming studio album Clockwork Angels, at Blackbird Studios in Nashville with Raskulinecz. "Caravan" and "BU2B" were released together on June 1, 2010, and made available for digital download.
Complications were observed in each of the leucotomy patients and included: "increased temperature, vomiting, bladder and bowel incontinence, diarrhea, and ocular affections such as ptosis and nystagmus, as well as psychological effects such as apathy, akinesia, lethargy, timing, and local disorientation, kleptomania, and abnormal sensations of hunger". Moniz asserted that these effects were transitory and, according to his published assessment, the outcome for these first twenty patients was that 35%, or seven cases, improved significantly, another 35% were somewhat improved and the remaining 30% (six cases) were unchanged. There were no deaths and he did not consider that any patients had deteriorated following leucotomy.
== Importance in nuclear reactors == If a nuclear reactor happened to be prompt critical – even very slightly – the number of neutrons would increase exponentially at a high rate, and very quickly the reactor would become uncontrollable by means of external mechanisms. The control of the power rise would then be left to its intrinsic physical stability factors, like the thermal dilatation of the core, or the increased resonance absorptions of neutrons, that usually tend to decrease the reactor's reactivity when temperature rises; but the reactor would run the risk of being damaged or destroyed by heat. However, thanks to the delayed neutrons, it is possible to leave the reactor in a subcritical state as far as only prompt neutrons are concerned: the delayed neutrons come a moment later, just in time to sustain the chain reaction when it is going to die out. In that regime, neutron production overall still grows exponentially, but on a time scale that is governed by the delayed neutron production, which is slow enough to be controlled (just as an otherwise unstable bicycle can be balanced because human reflexes are quick enough on the time scale of its instability). For example, with a neutron lifetime of 10−3 s and a reactivity step of 0.0022, the reactor period would be 0.45 s without delayed neutrons, but is 14 s with them. Thus, by widening the margins of non-operation and supercriticality and allowing more time to regulate the reactor, the delayed neutrons are essential to inherent reactor safety, even in reactors requiring active control.
Boron neutron capture therapeutics are pharmaceuticals intended for use to deliver boron-10 to cancerous cells as part of boron neutron capture therapy (BNCT). Boron-10 atoms strongly absorb neutrons to form a metastable state of boron-11, which undergoes α-decay. By accumulating boron-10 in cancerous cells and subjecting the tumor to neutron radiation, high-energy α particles are selectively delivered only to the target cells. This neutron bombardment results in the selective destruction of the tumor cells that the boron-10 was absorbed into. As of 2023, the technology is available in Japan only, and even there few implementations have been reported.
Sources: en.wikipedia.org
It is usually detected by LC-MS or HPLC-UV against a reference standard. In biological matrices, metabolite targeting can improve detection. No universal immunoassay is widely available.
The compound is generally handled as light-sensitive and stored cold and dry. Stability in solution depends on solvent, concentration, and storage time. Specific degradation rates are not fully standardized.
Limited water solubility affects formulation for cell and animal studies. Organic co-solvents are often used to dissolve it. Precipitation can confound assay results if not controlled.
Research-grade SR9009 is typically stored frozen at about minus twenty degrees Celsius, protected from light and moisture. Stock solutions are often kept in aliquots to avoid repeated freeze-thaw cycles. Specific storage conditions should follow the supplier's documentation.